Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 -2.56%61 EV-to-EBIT is 13.77 as of Aug. 05, 2026, which is 15% above its 10-year median of 12.01. GuruFocus rates XKLS:0243 with a GF Score™ of 61/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Cengild Medical Bhd ranks better than 57.66% on this metric.
The historical rank and industry rank for Cengild Medical Bhd's EV-to-EBIT or its related term are showing as below:
XKLS:0243'
s EV-to-EBIT Range Over the Past 10 Years
Min: 6.52 Med: 12.01 Max: 44.4
Current: 13.77
During the past 8 years, the highest EV-to-EBIT of Cengild Medical Bhd was 44.40. The lowest was 6.52. And the median was 12.01.
XKLS:0243's EV-to-EBIT is ranked better than 57.66% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 15.985
vs XKLS:0243: 13.77
Cengild Medical Bhd (XKLS:0243) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cengild Medical Bhd's Enterprise Value for the quarter that ended in Mar. 2026 was RM206.05 Mil.
Cengild Medical Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM13.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd EV-to-EBIT Related Terms
Cengild Medical Bhd EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cengild Medical Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's EV-to-EBIT falls into.
Cengild Medical Bhd's current Enterprise Value is RM189.40 Mil.
Cengild Medical Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM13.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd (XKLS:0243) has a EV-to-EBIT of 13.77 as of Aug. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cengild Medical Bhd and its competitors. This is 15% above median its historical median of 12.01. Over the past decade, Cengild Medical Bhd's EV-to-EBIT has ranged from 6.52 to 44.40. According to the industry distribution chart, Cengild Medical Bhd ranks #199 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 42.3%.
Is Cengild Medical Bhd's EV-to-EBIT too high?
Cengild Medical Bhd's current EV-to-EBIT of 13.77 is 15% above median its 10-year median of 12.01. Over the past 10 years, this metric has ranged from a low of 6.52 to a high of 44.40. The Healthcare Providers & Services industry median EV-to-EBIT is 15.99. Cengild Medical Bhd's value of 13.77 is 13.9% below this industry median. Based on the distribution chart, Cengild Medical Bhd ranks #199 out of 470 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #199 out of 470 companies for EV-to-EBIT. This puts Cengild Medical Bhd in the upper half of its industry. The industry median EV-to-EBIT is 15.99. Cengild Medical Bhd's value of 13.77 is 13.9% below this benchmark. Historically, Cengild Medical Bhd's own EV-to-EBIT has ranged from 6.52 to 44.40 over the past decade. While the company's 10-year median is 12.01 vs. the industry median of 15.99, Cengild Medical Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.99, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cengild Medical Bhd's current EV-to-EBIT of 13.77 is 13.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current EV-to-EBIT is 13.77, which is 15% above median its own 10-year median of 12.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current EV-to-EBIT is 13.77, which is 15% above median its 10-year median of 12.01 and 13.9% below the Healthcare Providers & Services industry median of 15.99. Cengild Medical Bhd's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current EV-to-EBIT is 13.77 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
EV-to-EBIT: 13.77 (15% above median its 10-year median of 12.01)
GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
Industry Position: 13.9% below the Healthcare Providers & Services median (#199 of 470)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
61GF Score
Get the complete analysis for XKLS:0243
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
